Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ZFYVE19 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA530855
Description
Recommended positive controls: 293T, A431, HeLa, HepG2, NIH-3T3, BCL-1. Predicted reactivity: Human (99%), Bovine (80%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Key regulator of abscission step in cytokinesis: part of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage. Together with CHMP4C, required to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ZFYVE19/ANCHR and VPS4 and subsequent abscission.
Specifications
ZFYVE19 | |
Polyclonal | |
Unconjugated | |
ZFYVE19 | |
1500041L05Rik; abscission/NoCut checkpoint regulator; ANCHR; MLL partner containing FYVE domain; MPFYVE; Zfyve19; Zinc finger FYVE domain-containing protein 19; zinc finger FYVE-type containing 19; zinc finger, FYVE domain containing 19 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
72008, 84936 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
Q96K21, Q9DAZ9 | |
ZFYVE19 | |
Recombinant protein fragment corresponding to a region within amino acids 140 and 312 of Human ZFYVE19. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction